Paradigm Biocapital Advisors LP
Holdings History for Lexeo Therapeutics, Inc. - Common Stock (LXEO)
- Symbol
- LXEO on Nasdaq
- Investment type
- Equity / Common Stock
- Latest Disclosed Shares Owned
- 4,763,198 shares
- Security Ownership %
- 6.5%
Shares, Excluding Options vs Price
Value, Excluding Options
Paradigm BioCapital Advisors LP ownership in Lexeo Therapeutics, Inc. Common Stock (LXEO)
17 Feb 2026 - Paradigm BioCapital Advisors LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 4,763,198 shares of Lexeo Therapeutics, Inc. Common Stock (LXEO).
This represents 6.5% ownership of the company.
In their previous filing dated 20 Nov 2025, Paradigm Biocapital Advisors LP had reported owning 3,671,999 shares, indicating an increase of +30%.
.
| Reporting Name | Ownership % | Change | Value $ | Shares owned | Change | Activity % | Price | Form | Report date | Filing time |
|---|---|---|---|---|---|---|---|---|---|---|
| Paradigm BioCapital Advisors LP | 6.5% | +30% | $35,390,561 | 4,763,198 | +1,091,199 | +30% | $7.43 | 13G/A | 31 Dec 2025 | 17 Feb 2026, 16:02 |
| Paradigm BioCapital Advisors LP | 5% | $33,047,991 | 3,671,999 | $9.00 | 13G | 13 Nov 2025 | 20 Nov 2025, 16:30 |
| Holdings date | Option | Weight | Change | Value $ | Shares | Change | Activity % | Price | All Holders |
|---|---|---|---|---|---|---|---|---|---|
| 31 Dec 2025 | 1.3% | +1.3% | $47,298,556 | 4,763,198 | +4,763,198 | NEW | $9.93 | Q4 2025 |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.